Efficacy of Oral BG-12 (Dimethyl Fumarate) in Patients Newly Diagnosed with Relapsing-Remitting Multiple Sclerosis (RRMS): Integrated Analysis of DEFINE and CONFIRM

被引：0
|
作者：
Gold, R. [1 ]
Giovannoni, G. [2 ]
Phillips, J. T. [3 ]
Fox, R. J. [4 ]
Rana, J. [5 ]
Zhang, A. [5 ]
Meltzer, L. [5 ]
Kurukulasuriya, N. C. [5 ]
机构：
[1] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[2] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[3] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[4] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[5] Biogen Idec Inc, Weston, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-65
引用
收藏
页码：931 / 932
页数：2
相关论文
共 50 条
  • [21] Advances in the management of relapsing-remitting multiple sclerosis: role of oral dimethyl fumarate (BG-12)
    Nielsen, A. Scott
    DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, 2015, 5
  • [22] Effect of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study
    Hutchinson, M.
    Fox, R. J.
    Miller, D.
    Phillips, J. T.
    Kita, M.
    Havrdova, E.
    Yang, M.
    Zhang, R.
    Novas, M.
    Viglietta, V.
    Dawson, K. T.
    JOURNAL OF NEUROLOGY, 2012, 259 : S105 - S106
  • [23] Effect of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM (comparator and an oral fumarate in relapsing-remitting multiple sclerosis) study
    Hutchinson, M.
    Fox, R. J.
    Miller, D.
    Phillips, J. T.
    Kita, M.
    Havrdova, E.
    O'Gorman, J.
    Yang, M.
    Novas, M.
    Viglietta, V.
    Dawson, K. T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 355 - 355
  • [24] 3-Year Follow-up of Oral BG-12 (Dimethyl Fumarate) for Relapsing-Remitting Multiple Sclerosis (RRMS): Integrated Clinical Outcomes from the DEFINE, CONFIRM, and ENDORSE Studies
    Gold, R.
    Phillips, J. T.
    Bar-Or, A.
    Hutchinson, M.
    Kappos, L.
    Rana, J.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Fox, R. J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 932 - 932
  • [25] Flushing and gastrointestinal tolerability events in relapsing remitting multiple sclerosis (RRMS) patients treated with oral BG-12 dimethyl fumarate) in the phase 3 DEFINE and CONFIRM trials
    Selmaj, K.
    Gold, R.
    Fox, R. J.
    Havrdova, E.
    Giovannoni, G.
    Pace, A.
    Novas, M.
    Meltzer, L.
    Hotermans, C.
    Viglietta, V.
    Phillips, J. T.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 221 - 221
  • [26] Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis
    Ruggieri, Serena
    Tortorella, Carla
    Gasperini, Claudio
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 229 - 239
  • [27] An integrated analysis of the clinical and neuroradiological effect of BG-12 (dimethyl fumarate) in subgroups of patients with relapsing-remitting multiple sclerosis from the phase 3 DEFINE and CONFIRM studies
    Bar-Or, A.
    Fox, R. J.
    Gold, R.
    Miller, D. H.
    Arnold, D. L.
    O'Gorman, J.
    Yang, M.
    Sheikh, S. I.
    Viglietta, V.
    Dawson, K. T.
    Hutchinson, M.
    JOURNAL OF NEUROLOGY, 2013, 260 : S13 - S13
  • [28] Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: subgroup analyses of the CONFIRM study
    Michael Hutchinson
    Robert J. Fox
    David H. Miller
    J. Theodore Phillips
    Mariko Kita
    Eva Havrdova
    John O’Gorman
    Ray Zhang
    Mark Novas
    Vissia Viglietta
    Katherine T. Dawson
    Journal of Neurology, 2013, 260 : 2286 - 2296
  • [29] Clinical efficacy of BG-12 (dimethyl fumarate) for relapsing remitting multiple sclerosis according to prior therapy: an integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Hutchinson, M.
    Gold, R.
    Fox, R. J.
    Havrdova, E.
    Giovannoni, G.
    Zhang, A.
    Hotermans, C.
    Stephan, M.
    Bar-Or, A.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 235 - 235
  • [30] Timecourse of Treatment Effects of BG-12 (Dimethyl Fumarate) for Relapsing-Remitting Multiple Sclerosis
    Kappos, Ludwig
    Giovannoni, Gavin
    Gold, Ralf
    Fox, Robert
    Phillips, J. Theodore
    Hotermans, Christophe
    Zhang, Annie
    Viglietta, Vissia
    Miller, David
    NEUROLOGY, 2013, 80
12345